Accendra Health (ACH) Non Operating Interest Expenses (2009 - 2026)

Accendra Health (ACH) has reported Non Operating Interest Expenses for 18 consecutive years, with $32.3 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 33.59% year-over-year to $32.3 million in Q1 2026; TTM through Mar 2026 was $115.3 million, a 8.41% increase from a year earlier, with the FY2025 full-year figure at $107.2 million, changed 0.36% from the prior year.
• Non Operating Interest Expenses was $32.3 million for Q1 2026 at Accendra Health, up from $27.9 million in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $42.2 million in Q1 2023 and troughed at -$4.3 million in Q4 2023.
• A 5-year average of $29.6 million and a median of $29.0 million in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses tumbled 110.41% in 2023 and soared 744.65% in 2024, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $41.2 million in 2022, then plunged by 110.41% to -$4.3 million in 2023, then jumped by 744.65% to $27.6 million in 2024, then advanced by 1.14% to $27.9 million in 2025, then rose by 15.81% to $32.3 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $32.3 million (Q1 2026), $27.9 million (Q4 2025), and $29.0 million (Q3 2025), per Business Quant data.